Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2 publications
Efficacy and safety of insulin degludec in a flexible dosing regimen vs insulin glargine in patients with type 1 diabetes (BEGIN: Flex T1): a 26-week randomized, treat-to-target trial with a 26-week extension.
Journal: The Journal of clinical endocrinology and metabolism
Published: February 09, 2013
Insulin degludec: a novel ultra-long-acting basal insulin for use in Type 1 and 2 diabetes.
Journal: Expert review of endocrinology & metabolism
Published: January 01, 2012
Showing 1-2 of 2
Last Updated: 09/26/2026